🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Non-Helium Magnetoencephalography in Pediatric Brain Tumors

Recruitingn/aAges 3 Years - 18 YearsAllGuangzhou Women and Children's Medical Center
NCT06943742 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational study aims to evaluate the effectiveness of magnetoencephalography (MEG) in the preoperative assessment of pediatric brain tumors, particularly in determining the extent of resection, and compare it with computed tomography (CT) and magnetic resonance imaging (MRI). The main questions this study aims to answer are: What is the consistency between MEG and CT/MRI in localizing pediatric brain tumors? What is the clinical efficacy of MEG in determining the extent of resection of pediatric brain tumors preoperatively? Participants will: Undergo both MEG and CT/MRI examinations for preoperative assessment, and the extent of tumor resection will be determined by the comprehensive results of the above examinations. Be followed up with MEG and CT/MRI at 1, 3, and 6 months after surgery, along with neurological and quality-of-life assessments.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age range: 3-18 years old; * Clinically diagnosed with brain tumor; * Capable of cooperating with magnetoencephalography evaluation and recording. Exclusion Criteria: * Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination. * Patients using drugs that affect central nervous system function; * Patients who are not suitable for surgical procedures; * Patients with progressive neurological disorders.
💊

What it tests

  • Magnetoencephalography plus Computed Tomography/Magnetic Resonance Imaging
📍

Where

1 site
Guangzhou Women and Children's medical center
Guangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy